Platelet Rich Plasma Treatment for Male Infertility

Age: 18+

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Stanford University

No Placebo Group

Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

This trial is testing whether injecting a special substance made from a patient's own blood into their testicles can help men who couldn't retrieve sperm in a previous procedure. The goal is to see if this treatment can improve their chances of having children through medical procedures.

Research Team

Eligibility Criteria

This trial is for men over 18 with nonobstructive azoospermia (NOA) who have had an unsuccessful testicular sperm extraction (TESE). It's aimed at those seeking new options after traditional fertility treatments haven't worked.

Inclusion Criteria

You are over the age of 18 and have a history of NOA.

Exclusion Criteria

I'm sorry, but there is no criterion provided. Could you please provide me with more information?

Treatment Details

Interventions

• Platelet Rich Plasma (Other)

Trial Overview The study tests whether injecting platelet rich plasma (PRP) directly into the testes can increase the chances of finding sperm during a repeat TESE and improve in vitro fertilization (IVF) results for these men.

Participant Groups

Group I: Platelet rich plasma treatment arm Experimental Treatment 1 Intervention

After consent in obtained, the patient will undergo a blood draw (12 tsp) to prepare the PRP infusion. The use of a centrifuge and an Arteriocyte Magellan kit are necessary for the PRP preparation. After injection of local anesthesia, PRP will be injected into each testicle.

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials

2,527

Recruited

17,430,000+

Dr. Richard A. Miller

Stanford University

Chief Executive Officer since 2023

Stanford University, MD

Dr. Robert Schott

Stanford University

Chief Medical Officer since 2021

University of Michigan, MD